Clinexpert Gyongyos Kft

Gyöngyös 3200

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Colorectal Cancer, Crohn Disease, Moderately to Severely Active Crohns Disease, Non-Small Cell Lung Cancer

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation — Running, not enrolling